Brookline Capital Management Predicts BIOX FY2026 Earnings

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Brookline Capital Management decreased their FY2026 earnings estimates for shares of Bioceres Crop Solutions in a report issued on Thursday, February 13th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of $0.46 for the year, down from their previous estimate of $0.61. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.12 per share.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.11). The firm had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same period in the previous year, the firm earned ($0.07) EPS.

Other research analysts have also issued reports about the company. Oppenheimer lowered their target price on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating on the stock in a report on Tuesday, January 28th. Lake Street Capital lowered their price objective on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating on the stock in a research note on Friday, February 7th. Finally, Canaccord Genuity Group cut their target price on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating for the company in a research note on Thursday. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Bioceres Crop Solutions currently has a consensus rating of “Buy” and a consensus price target of $9.88.

Bioceres Crop Solutions Stock Down 0.8 %

Shares of BIOX stock opened at $4.74 on Friday. Bioceres Crop Solutions has a 1 year low of $4.66 and a 1 year high of $13.80. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.87 and a current ratio of 1.27. The business’s fifty day moving average is $6.49 and its 200-day moving average is $7.66. The stock has a market cap of $297.25 million, a PE ratio of 237.12 and a beta of 0.57.

Institutional Trading of Bioceres Crop Solutions

Several institutional investors and hedge funds have recently bought and sold shares of BIOX. Jump Financial LLC purchased a new position in shares of Bioceres Crop Solutions in the fourth quarter worth approximately $72,000. Ping Capital Management Inc. boosted its stake in Bioceres Crop Solutions by 7.3% in the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock worth $268,000 after purchasing an additional 3,000 shares during the period. Stifel Financial Corp grew its position in Bioceres Crop Solutions by 33.4% during the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after purchasing an additional 10,224 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Bioceres Crop Solutions by 17.0% during the 4th quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company’s stock valued at $640,000 after purchasing an additional 15,328 shares during the period. Finally, Ballast Asset Management LP lifted its holdings in shares of Bioceres Crop Solutions by 23.5% in the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock valued at $2,620,000 after purchasing an additional 82,187 shares in the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.